Chinese Journal of Cancer
Overview
Chinese Journal of Cancer is a scientific journal, published by Biomed Central since 2008 in English. The journal's country of origin is United Kingdom and its primary focus area is oncology.
Details
Details
Abbr.
Chin J Cancer
Publisher
Biomed Central
Start
2008
End
2018
Frequency
Monthly
p-ISSN
1000-467X
e-ISSN
1944-446X
Country
United Kingdom
Language
English
Specialty
Oncology
Recent Articles
1.
Li M, Ma F, Wang J, Li Q, Zhang P, Yuan P, et al.
Chin J Cancer
. 2018 Feb;
37(1):4.
PMID: 29382381
Background: Autophagy plays a crucial role in chemotherapy resistance of triple-negative breast cancer (TNBC). Hence, autophagy-related gene 5 (ATG5), an essential molecule involved in autophagy regulation, is presumably associated with...
2.
Li Y, Diao F, Shi S, Li K, Zhu W, Wu S, et al.
Chin J Cancer
. 2018 Jan;
37(1):3.
PMID: 29370848
Background: Accurate evaluation of lymph node metastasis in bladder cancer (BCa) is important for disease staging, treatment selection, and prognosis prediction. In this study, we aimed to evaluate the diagnostic...
3.
Chin J Cancer
. 2018 Jan;
37(1):1.
PMID: 29357949
Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology, which spark diverse thoughts, interesting communications, and potential...
4.
Liu Y, Tan X, Liu W, Chen X, Hou X, Shen D, et al.
Chin J Cancer
. 2018 Jan;
37(1):2.
PMID: 29357946
Background: We previously showed that the expression of follistatin-like protein 1 (FSTL1) was significantly down-regulated in metastatic clear-cell renal cell carcinoma (ccRCC). In this study, we aimed to characterize the...
5.
Yao J, Zhou G, Wang Y, Wang S, Zhang W, Jin Y, et al.
Chin J Cancer
. 2017 Dec;
36(1):98.
PMID: 29284539
Background: According to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system, over 50% of patients with nasopharyngeal carcinoma (NPC) have N1 disease at initial diagnosis....
6.
Xu R, Shen L, Wang K, Wu G, Shi C, Ding K, et al.
Chin J Cancer
. 2017 Dec;
36(1):97.
PMID: 29273089
Background: Metastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies need new medication for further treatment. Famitinib is a small-molecule multikinase inhibitor, with promising anticancer activities....
7.
Peng J, Zhang R, Zhao Y, Wu X, Chen G, Wan D, et al.
Chin J Cancer
. 2017 Dec;
36(1):96.
PMID: 29268783
Background: The prognostic nutritional index (PNI) has been widely applied for predicting survival outcomes of patients with various malignant tumors. Although a low PNI predicts poor prognosis in patients with...
8.
Peng H, Chen L, Tang L, Li W, Mao Y, Guo R, et al.
Chin J Cancer
. 2017 Dec;
36(1):95.
PMID: 29258597
Background: Little is known about the nature of metastasis to small cervical lymph nodes (SCLNs) in the patients with nasopharyngeal carcinoma (NPC) examined by using 18-fluoro-2-deoxy-glucose (F-FDG) positron emission tomography/computed...
9.
Hu L, Xu X, Rao H, Chen J, Lai R, Huang H, et al.
Chin J Cancer
. 2017 Dec;
36(1):94.
PMID: 29246182
Background: The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral...
10.
Ma L, Qiu B, Zhang J, Li Q, Wang B, Zhang X, et al.
Chin J Cancer
. 2017 Dec;
36(1):93.
PMID: 29228994
Background: Locoregional recurrence remains the challenge for long-term survival of non-small cell lung cancer (NSCLC) patients after radical surgery, and curative-intent radiotherapy could be a treatment choice. This study aimed...